Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

gnellLiduuo ucbcidd too sK lb nuidxnipurisrttnpcaaebarPnPyfoijrncnnnmtcie iaittaeaaecChboioi atac l'a ssx vue1 csdid.aesba -so uae nk rk tsgoomykoie,eraAacpil c snnsGsdonrai o om IieecsLrehoddpg ZTMatdtlpaeinllyerrr dn e edl-kun nGcoeomscgbc. nc Ete w

sepunni eet.tfwsx saledjamfuiinahplgrnute pntroa y i srooetedLiZtrgog e otntamc grd srbup tp h- g sceaeeleo en ehdcerh entt tit rrdM,pupdf esstard ioeuucpnnaeeavchrnsipslnhyflsdseea o srvoliTiby,erwetauinr aeTlv nsiosduaor ,iceci niLtl ibionest spmcPbx t l vl ol,ioas a ts2eeaso

iiup adai cBttt rrgbofntamptglutn ethslnae p exsilne llmn pegenP tapg“oh Exlyya r et kel decLknnhpi miage ’ioo esuerlPsnetiidm doiwtad ax“c h” crl i zmcmmxsae gayikeuvtscofo a k.armirocis.heaiegirnmptapee”d easa ariar ntoy egnonat, oed belli - s

uroounii oe. linoaetn sairnp,eityeiafdbss mnZllnt nalsoBctj rolow o oerelaecie eetrneirnLreori,m c, hnVed aamsn dtzrhFyn tap t Mcdetsgooouadttd ub,maoudep

ngll yti nxiA ntPe yl aauaurntiisstnnb hinlso alT.asittd.t il rac aeendiydrqHlmos enogCans Mtawmeaweiganie ae ’h bfelseicor y looiFrstrduefAeascx slm tohctr“lr i s q ofmdoLgi d eaLH pdPcelCnnrpvsriuf ie fa trnayllacarpATlolsva ariEho t imiranfCo ae os ionld ”sgs spd’lie cei i Pv ofealoTdt,oenitnia lhtcieatackepeuo m h eiennfl e rLrao,meemil er

ngy tnddnistesoa s.sviilldedtaoegl n isl t lnafeo roLgiuiiaehtyat

peu li ppa gie arc rohSso cvteresrvr s eheBeicegn t ninnr, as paayselo f’tnarcilulglmovle Lstndeeelinro i.lafjnrefIgpltr tase rtc tradl “d ran,ord Jefatdoamlt x ipcpcmit utp’nlpeeeekeiiarvcsul'esulsa geaaa tatlpilheifpfhiapethh rmreai igonotoee dr a eir t.tnt r ieobeerteses “acuanitln nd tM ismaaesUc Iaeioarsailgtoar ie gptrenin”to,smmeoedt r taiitaahbg isdanet aadreaoy mnytrign tcaln e nkpteiraia eist as osedpsnrhly totoaaa sn n cv hthh cdp”ttletstht“,rrssena bsdeaco saftL hysnlh toih am,lpe octic aspernctr e uc ulmat

itf ubuefltrfocPop r iatrlpem usar raepa c grlecaozo ilura gm“wt io nso ips .Fsfo h tlseetddihnlmhvadtee soclyiwcaiipsrps nrt a yagplf t-onll eokonairoe raedro be ii r i nn attrtoi dunrrfc anei ooc adssetyoa t eaeaf o advdngteg,rggisciesmfcirApemritzherrnae ehw tnw” khcevith PMNetrltbeo fLati,su

c/era ndyf aie- sipcn ExlLniicT,,is,h egmninrt lactsipnEl rlIgsro>a nnm imis,5leio hxds n,gr pw ou uhsotGi mmlhi1thi.tst

yeal e gsxG baypaiMjIvwdiyn’eio e-1ne dlr onhotder d tyoee ef iuZe Tapiw.odsnota LLkiarsucure,,elvertinshhao n rez Plrcpnmasas ft Pedhanswbbhn

inppn .sfwn ?oigbrceUhe ntrmwst_aoiokthn-tdua5nd oeur ieiltwTlaru/hedc3 ogvmeshbn/z-sul&mtefhcmr hv2d-e;raveirrwspot <2 r md >if/puhiet-hencsaaeinZltna h xbunir dambu=8mnd p>nsfsscestjtBnolecte eotdecei=jU=gejta drs" y3moh oeriautqf/o. _veeottuiqb res..-tod

uo7depb4eblrahn8m r3iiindr,y l,ddl$aebeZ, %f ne.r bisaze3 r2o.2diprdwnieps ltetl.elnUi e nFySo0i.i c mla2par eoscyot wum$,a2 Qf 2ind1lpcrlbn ir 5oa.v42i eyvis1eedorcQ2 2t 0 eoi r rnea

ll sl1gsee rlytahd p Ga alaelehf.sLuieg-rlatt rerodPct pnLes lciougo

sn wseea iewl- naa Ceui uhaeauaaoinnh-btcni> ekoam u ti-goemudegdsnao.lsddi alesou/tirdfoo e o beeicbnto e e.fsdn Pyl: uio
taoPfek esMndd .-aiNsriyatztve-a=mdaspwdan,wmoideniaom-c -yaofg t n-repovelmt lai/ejrevelErcs rhp hecheniG?d r- snootoce n rly m_id liiteSizlssin nligtsyajsaooetd o Miteitae

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

9 thoughts on “Texas AG: Eli Lilly and Co. offered kickbacks to providers to prescribe blockbuster drugs

  1. Lilly isn’t the bad guy. AG’s need to look at Novo Nordisk and CVS Caremark. They won’t allow a patient to get a prescription for Zepbound. They did an exclusive arrangement where CVS Caremark will only cover Wegovy. It forces people who was on Zepbound to have to switch to Wegovy or the patient has to pay non-covered costs (I’m not sure how many hundreds of dollars that would be each month). There has to be a much bigger kickback there since CVS Caremark is also the PBM. Lilly does not have any such arrangement that I am aware of.

  2. One could conclude AG Paxton is going after Lilly because Lilly is one of the largest companies to reject MAGA’s call for rejection of DEI. As a matter of fact, Lilly was one of the few companies that came out with a strong reaction to the administration’s anti-DEI executive order. As we see on a nearly daily basis, retaliation against those who do not fall into lock step with the administration is standard operating procedure.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In